SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
CAVA Group amended its Executive Severance Plan with material changes to eligibility, severance benefit conditions, offset provisions, and change-of-control standstill periods, affecting compensatory arrangements for directors and officers.
View raw filing on EDGAR →The disclosure centers on amended and restated employment and change of control agreements for five named officers (Van Dyke, Langs, Bell, Speare, and Kallsen), updating their compensatory arrangements and severance terms to comply with new Virginia law effective July 1, 2026, and reflecting current base salaries and positions. This is a classic Item 5.02(e) compensatory arrangement disclosure, distinct from a departure or appointment, and material because it modifies severance, clawback, and restrictive covenant provisions for senior executives.
View raw filing on EDGAR →The disclosure centers on amended and restated employment agreements for two named executives (Ryan R. Smith and Jamie M. Schnur) that modify their compensatory arrangements, including severance multiples, payment periods, and post-employment benefits. While the agreements also address termination conditions, the principal disclosed action is the modification of executive compensation terms—specifically reducing Mr. Smith's severance multiple from 3x to 2x base salary and shortening restrictive covenant periods from 36 to 24 months. This is a classic exec_compensation event under Item 5.02(e).
View raw filing on EDGAR →The Board approved amended compensation arrangements for non-employee directors, including increases to annual cash retainers (base retainer increased $5,000 to $80,000; committee chair retainers increased $2,500–$5,000; Board Chair retainer increased $5,000 to $60,000) and restricted stock unit awards (base award increased $15,000 to $140,000; Board Chair award increased $10,000 to $70,000). This is a material compensatory arrangement disclosure under Item 5.02(e), affecting director compensation structure and equity grants.
View raw filing on EDGAR →Stockholders approved and adopted the FibroBiologics, Inc. 2026 Equity and Incentive Compensation Plan, which authorizes 2,061,968 shares and enables the Compensation Committee to grant equity-based and cash-based compensation to employees, officers, consultants, and directors, including performance-based awards and evergreen provisions.
View raw filing on EDGAR →The filing discloses Item 5.02 approval by the Compensation Committee of one-time special discretionary cash bonus awards to the CEO ($250,000) and CFO ($100,000), explicitly recognizing their contributions to the Company's NYSE American listing, strategic repositioning toward AI/HPC infrastructure, and data center pipeline development. This is a compensatory arrangement for named executives, distinct from a departure or appointment.
View raw filing on EDGAR →This Item 5.02(e) disclosure describes grants of restricted stock units (RSUs) and performance-based restricted stock units (PBRSUs) to named executives including CEO J. Douglas Schick (22,830 RSUs + 15,220 PBRSUs), EVP/General Counsel Clark Moore (18,950 RSUs + 5,270 PBRSUs), Chief Commercial Officer Jody Crook (16,050 RSUs + 7,020 PBRSUs), and other employees, approved by the Compensation Committee as part of the 2025 annual compensation review. This is a classic compensatory arrangement disclosure under Item 5.02(e), distinct from an appointment or departure.
View raw filing on EDGAR →The 6-K discloses a Board-approved amendment to the Mynd.ai Equity Incentive Plan on June 17, 2026, increasing available shares by 106,000,000 Ordinary Shares. This is a material amendment to a compensatory arrangement affecting equity grants to directors, officers, and employees. The substantial one-time increase to the equity pool, combined with the existing evergreen provision, materially expands the Company's capacity to grant equity awards and would affect investor assessment of dilution and executive compensation practices.
View raw filing on EDGAR →Stockholders approved an amendment and restatement of the Company's 2000 Long-Term Incentive Plan, which reserves 10,717,500 shares for issuance as stock options, restricted stock, deferred stock, and other awards to directors, officers, and employees.
View raw filing on EDGAR →This exhibit is a supplemental letter to Tower's proxy statement seeking shareholder approval of an amended and restated compensation policy for directors and executive officers under Israeli law. The letter details proposed changes to compensation arrangements, including increases to CEO maximum annual bonus (175% to 225% of salary), CEO equity award limits (10x to 13x salary), and other executive officer compensation caps. These are material compensatory arrangements requiring shareholder approval under Section 5.02(e) of the 8-K taxonomy and Israeli corporate governance law.
View raw filing on EDGAR →The disclosure centers on a new employment agreement with CEO Ramesh Srinivasan that establishes compensatory arrangements: a $600,000 base salary, annual bonus eligibility up to 150% of base salary, and a substantial $6.8 million RSU grant (78,269 units) with both time-based and performance-based vesting conditions tied to stock price targets ($105–$135 per share). The agreement also specifies severance and change-of-control provisions. This is a material executive compensation arrangement under Item 5.02(e).
View raw filing on EDGAR →Stockholders approved amendments to the Company's 2015 Equity Incentive Plan (increasing authorized shares by 6.5 million) and the Employee Stock Purchase Plan (increasing authorized shares by 1 million), expanding the pool of shares available for equity compensation and employee stock purchase eligibility.
View raw filing on EDGAR →The disclosure centers on compensatory arrangements approved by the Compensation Committee for Branislav Vajdic, the Company's President and Founder, including a 2.8 million PRSU award under the 2022 Equity Incentive Plan and a transaction bonus agreement tied to change-of-control milestones. This is a classic exec_compensation event under Item 5.02(e), distinct from appointment or departure, and is material given the substantial equity grant and transaction-contingent bonus to a named executive officer.
View raw filing on EDGAR →The filing discloses under Item 5.02 that the board approved annual compensation of $150,000 for Dr. Amy T. Clemens, who was recently appointed as Chief Financial Officer on June 4, 2026. While the appointment itself occurred previously, the principal disclosed action in this 8-K is the board's approval of her compensatory arrangement, making this an executive compensation disclosure rather than an appointment event.
View raw filing on EDGAR →The disclosure announces a new CEO contract for Michael O'Leary extending to April 2032, including a modest annual salary, capped annual bonus, and a one-off equity purchase option over 10 million shares with performance-based vesting conditions tied to PAT growth (€4.0bn) or share price targets (€42 or $102). This is a material compensatory arrangement for a named executive officer that would affect investor assessment of executive incentives and long-term leadership continuity.
View raw filing on EDGAR →This 6-K discloses a grant of 10 million share options to Michael O'Leary, Group Chief Executive Officer, at a strike price of €26.70 under the Ryanair Holdings plc 2019 Long Term Incentive Plan. This is a compensatory arrangement for a named executive officer and falls squarely within exec_compensation disclosure requirements under Article 19 of the EU Market Abuse Regulation. The materiality is high given the size of the grant (10 million options) and the executive's senior position.
View raw filing on EDGAR →Stockholders approved the Hawkeye Digital, Inc. 2026 Equity Incentive Plan, a compensatory arrangement designed to provide equity incentives to employees, consultants, and directors.
View raw filing on EDGAR →The disclosure centers on a Third Amended and Restated Employment Agreement with John H. Tyson, the Chairman, detailing comprehensive compensatory arrangements including a $3.5M annual base salary, 300% target annual incentive, $6M long-term incentive grants, a $40M one-time cash payment, aircraft use, personal security services, and severance provisions. This is a material executive compensation arrangement requiring 8-K disclosure under Item 5.02(e).
View raw filing on EDGAR →The Board approved and stockholders ratified amendments to the Willdan Group 2008 Performance Incentive Plan, including a 380,000-share increase in available awards and extension of the plan term to 2036, materially affecting future dilution and executive compensation capacity.
View raw filing on EDGAR →The filing discloses multiple compensatory arrangements approved by the Board on June 18, 2026: (1) an updated non-employee director compensation program with specified annual cash retainers; (2) a $5.0 million change-in-control Retention and Incentive Plan with annual CPI-U adjustments; (3) a performance-based Waterfall Merger Incentive Program tied to IRR thresholds; and (4) confirmation of vesting of 35,419 RSUs under the 2020 LTIP. These are material compensation arrangements that would affect investor assessment of executive incentives and retention structures.
View raw filing on EDGAR →This exhibit discloses a partial amendment to Toyota's share-based compensation plan for employees in "Senior Professional / Senior Management (Kanbushoku)" positions. The amendments modify vesting dates (from "first business day of August immediately following retirement" to "the date on which the Eligible Employee retires") and add provisions for employees becoming residents of countries not covered by the Plan. These changes materially affect the compensatory arrangements and timing of equity delivery for named executives and senior management, falling squarely within the exec_compensation category.
View raw filing on EDGAR →The filing discloses adoption of new forms of equity award agreements (RSU, stock option, and common stock agreements) under the 2021 Incentive Award Plan and grants of time-based RSUs to three named executive officers (Dave Lillis, Jeff Mayfield, and Ryan Salmons) totaling approximately $319,636 in aggregate grant-date fair value. Item 5.02(e) explicitly identifies these as "material compensatory arrangements," and the disclosure details vesting structures, fair values, and vesting commencement dates for each executive.
View raw filing on EDGAR →The Board adopted a Nonqualified Deferred Compensation Plan for named executive officers and directors, and entered into a consulting agreement with Dr. Rebecca Taub (Class II director) providing $100,000 annually plus director compensation. These compensatory arrangements were approved by stockholders as part of the Annual Meeting voting on the 2026 Stock Plan and 2026 Employee Stock Purchase Plan.
View raw filing on EDGAR →The 6-K discloses a grant of options under the "Foundation Plan for Growth" to 12 PDMRs (persons discharging managerial responsibilities), including the CEO, CFO, and other named executives. The announcement details the vesting conditions (50% after three years, 50% after four years, subject to TSR performance), exercise prices, and aggregate grant values (totaling approximately €109.8 million across all recipients). This is a material compensatory arrangement affecting senior executives' equity interests, falling squarely within exec_compensation disclosure requirements under Market Abuse Regulation 596/2014.
View raw filing on EDGAR →The exhibit discloses equity compensation grants to directors, officers, employees, and consultants: 201,969 stock options at $2.30 per share and 266,035 restricted share units, approved by the Board on June 11, 2026, with three-year vesting schedules. While the press release also announces receipt of a $50,000 government grant for exploration (operational/financial), the substantive disclosure requiring classification under 8-K Item 5.02(e) standards is the equity award grant, which is material to investors assessing management incentive alignment and potential dilution.
View raw filing on EDGAR →The filing discloses a material compensatory arrangement: the Board approved a grant of 271,076 performance-based restricted stock units (PSUs) to CEO Dr. KR Sridhar on June 15, 2026, under the 2018 Equity Incentive Plan. The award is conditioned on objective revenue and margin targets through 2029 and includes a holding requirement through 2031, designed to retain the CEO and align his incentives with strategic growth priorities. This is a classic equity compensation disclosure under Item 5.02(e).
View raw filing on EDGAR →The filing discloses Compensation Committee approval of annual base salary adjustments for three named executives: Louis Hoch (CEO) at $995,000, Greg Carter (SVP, Chief Accounting Officer) at $325,000, and Michael White (SVP, Chief Accounting Officer) at $260,000, all effective August 3, 2026. This is a direct disclosure of compensatory arrangements under Item 5.02(e), which is material to investors assessing executive compensation practices.
View raw filing on EDGAR →The disclosure centers on the Compensation Committee's approval of equity awards (1,961,986 PSUs and 783,618 RSUs) granted to executive officers including the CEO, CFO, and Chief Accounting Officer under the 2026 Equity Incentive Plan. This is a classic compensatory arrangement disclosure under Item 5.02(e), with specific vesting schedules and performance targets tied to stock price appreciation over three years. The awards represent 37% of authorized shares and are material to investor assessment of executive compensation.
View raw filing on EDGAR →The Compensation Committee approved and adopted the Senior Executive Annual Bonus Plan on June 15, 2026, establishing a compensatory arrangement for executive officers and designated employees. The plan specifies performance metrics, payment mechanisms (cash or stock under the 2022 Equity Incentive Plan), and clawback provisions. This is a material disclosure of a new compensation plan affecting executive officers, fitting squarely within the exec_compensation category.
View raw filing on EDGAR →The filing discloses a letter agreement with Stavros Vizirgianakis, the Chairman, in connection with his appointment as Executive Chairman. The material substance is the Board's approval of a 450,000 RSU grant under the 2023 Share Incentive Plan with a three-tranche vesting schedule. While the appointment itself is mentioned, the filing centers on the compensatory arrangement—the equity grant—which is the principal disclosed action and would materially affect investor assessment of executive compensation and dilution.
View raw filing on EDGAR →Urban One entered into a new employment agreement with CFO Peter D. Thompson establishing comprehensive compensatory arrangements including a $750,000 base salary, $333,333 signing bonus, annual performance bonuses up to $300,000, a $850,000 completion bonus contingent on remediation of material weaknesses, and stock-based compensation grants totaling over $1.8 million through January 6, 2029.
View raw filing on EDGAR →Kanzhun granted 550,498 RSU share awards to 45 employees on June 15, 2026, pursuant to the Post-IPO Share Scheme, with vesting schedules ranging from 2–4 years, performance targets covering 84.87% of awards, and clawback provisions.
View raw filing on EDGAR →The disclosure centers on an Amended and Restated Employment Agreement with Chad Cowan, Ph.D., the Chief Scientific Officer, modifying his compensation structure to part-time status with a reduced annual salary of $296,150 and pro-rated performance-based bonus eligibility. While the agreement also addresses termination provisions, the principal disclosed action is a compensatory arrangement modification for a named executive officer, which falls squarely within exec_compensation rather than exec_departure (no departure occurred) or exec_appointment (no new role assumed).
View raw filing on EDGAR →Shareholders approved an amended and restated 2013 Performance Incentive Plan that increases the share pool by 8.8 million shares (from 48.0 to 56.8 million) and extends the plan expiration to 2036, materially expanding equity award capacity for officers, directors, and employees.
View raw filing on EDGAR →The primary disclosure in Item 5.02 is the Board-approved compensation increase for CFO Tiago Miranda, effective immediately, including a base salary increase to $360,000 (retroactive to May 29, 2026), a cash bonus opportunity of up to $120,000, RSU grants valued at $480,000 vesting over four years, and a $20,000 one-time bonus. While Item 8.01 also discloses resolution of Brazilian litigation regarding a community consultation, the filing's substantive focus and Item 5.02 designation center on the executive compensation arrangement reflected in the Amended and Restated Employment Agreement.
View raw filing on EDGAR →The disclosure centers on a new employment agreement with Charles Schoch, the CFO, setting forth compensatory arrangements including base salary ($468,600), annual bonus (40% target), severance provisions (nine months base plus target bonus), COBRA continuation, and equity acceleration upon change of control. This is a classic executive compensation arrangement disclosure under Item 5.02(e), material because it establishes the CFO's compensation terms and change-of-control protections.
View raw filing on EDGAR →The news release announces the grant of 750,000 incentive stock options to "certain directors and officers" pursuant to the Company's Stock Option Plan, with an exercise price of $0.55 per share and a 5-year term. This is a compensatory arrangement for named executives and directors, falling squarely within the exec_compensation category. The grant is material as it represents a significant equity incentive to leadership.
View raw filing on EDGAR →Shareholders approved an amendment to the Company's 2014 Share Incentive Plan to increase the number of ordinary shares reserved for issuance, effective June 10, 2026. This amendment expands the equity compensation pool available for directors and officers.
View raw filing on EDGAR →The disclosure centers on an amendment to Jillian C. Evanko's Senior Advisor Agreement that modifies compensatory arrangements, including a termination date and fixed fee structure. While the amendment also contemplates the eventual end of her advisory services, the substantive disclosure focuses on the modification of compensation terms and conditions, making this primarily an exec_compensation event rather than a departure.
View raw filing on EDGAR →The disclosure describes establishment of a formal compensation plan for non-employee directors, specifying annual cash compensation ($100,000) and equity grants (750 restricted shares). This is a compensatory arrangement for directors that would materially affect investor assessment of governance and executive costs. While filed under Item 1.01 (typically for M&A), the substance is director compensation plan adoption, which falls under exec_compensation.
View raw filing on EDGAR →Stockholders approved an amendment to the 2023 Incentive Compensation Plan increasing authorized shares from 138,861 to 520,000 and raising the annual non-employee director award limit from 2,500 to 75,000 shares, materially expanding equity grant capacity for executives and directors.
View raw filing on EDGAR →Stockholders approved an amendment to the 2024 Equity Incentive Plan increasing available shares by 1,600,000 shares (approximately 3.1% of outstanding common shares), expanding the pool of equity available for grants to officers and directors.
View raw filing on EDGAR →The filing discloses two material events under Item 5.02 and Item 5.07. The primary substantive disclosure is the Compensation Committee's approval on June 11, 2026 of an increase to CEO Vininder Singh's annual base salary from $400,000 to $600,000 (a 50% increase) and modification of his target annual bonus to a maximum of 50% of base salary. While the filing also reports shareholder vote results (Item 5.07), the compensation arrangement is the more significant material event requiring disclosure, as it represents a substantial change to executive compensation that would affect investor assessment of the company's cost structure and executive incentives.
View raw filing on EDGAR →The disclosure centers on amendments to Adam K. Bowen's compensatory and employment arrangements as Interim CFO, including modifications to base salary, bonus structure, discretionary cash awards ($100,000 initial plus conditional quarterly awards), and LTI equity vesting terms. While the filing is under Item 5.02, the substantive focus is on compensation modifications rather than a departure or appointment event, making exec_compensation the most precise classification.
View raw filing on EDGAR →Adoption of amended and restated equity incentive plans (the A&R 2024 Plan and Second A&R ESPP) in connection with the Company's IPO, establishing the framework for compensatory equity awards to directors, officers, and employees with hundreds of millions of shares reserved.
View raw filing on EDGAR →Shareholders approved the Fourth Amended and Restated 2019 Incentive Award Plan, which materially expands the equity compensation framework by increasing available shares by 9.45 million and extending the grant period through 2036.
View raw filing on EDGAR →The disclosure centers on compensatory arrangements for Swen Neufeldt, a Group Vice President, including modifications to his base salary structure (addition of $56,103 cost-of-living adjustment), relocation payments ($20,000), housing allowance ($90,566 annually), and various other benefits totaling substantial additional compensation tied to his international assignment. While the assignment itself is administrative, the material substance of the 8-K Item 5.02 filing is the new compensatory package and benefits arrangement.
View raw filing on EDGAR →The Board approved the Annual Incentive Bonus Plan for fiscal 2027 on June 11, 2026, establishing compensatory arrangements for executive officers including target award opportunities (165% of base salary for CEO, 115% for CFO, 100-110% for other NEOs) and performance metrics tied to operating profit, free cash flow, and revenue. This is a classic Item 5.02(e) disclosure of executive compensation plan terms and is material to investors assessing executive incentive structures.
View raw filing on EDGAR →The Compensation Committee approved a form of Restricted Stock Unit Award Agreement under the 2026 Incentive Plan on June 10, 2026. This is a compensatory arrangement for officers and directors involving equity grants, which falls squarely within the exec_compensation category. The approval of a plan form document that will govern future RSU awards is material to investors assessing executive compensation practices.
View raw filing on EDGAR →This announcement discloses a grant of 737,054 RSUs to 302 employees under the Company's 2021 Plan on June 12, 2026. The disclosure details the vesting schedules, market prices, clawback mechanisms, and the Board's rationale for the grants as a compensation and retention mechanism. This is a material compensatory arrangement for employees that affects the Company's capital structure and incentive programs, consistent with Item 5.02(e) disclosure of executive and employee compensation arrangements.
View raw filing on EDGAR →